MP23-20 PROBIOTICS IN RECURRENT UTIS: COLLECTIVE INFORMATION ON COMMERCIALLY AVAILABLE PRODUCTS | Zendy

Lyfong Lor | Zendy; Daniel A. Igel | Zendy; Majid Mirzazadeh | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

MP23-20 PROBIOTICS IN RECURRENT UTIS: COLLECTIVE INFORMATION ON COMMERCIALLY AVAILABLE PRODUCTS

Author(s) -

Lyfong Lor,

Daniel A. Igel,

Majid Mirzazadeh

Publication year - 2018

Publication title -

the journal of urology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.402

H-Index - 256

eISSN - 1527-3792

pISSN - 0022-5347

DOI - 10.1016/j.juro.2018.02.752

Subject(s) - medicine , probiotic , lactobacillus acidophilus , pharmacy , genitourinary system , family medicine , biology , genetics , bacteria

• Probiotics consist of live micro-organisms that can improve patient wellbeing. The mechanism of action of probiotics includes mucosal barrier maintenance, resistance to colonization, and inactivating bacterial toxins and virulence factors1 • Emergence of multi-drug resistant organisms has stimulated interest in non-antibiotic methods for prevention of urinary tract infection (UTI), such as probiotics2 • Probiotics have become increasingly popular. Between 2007 and 2012, the number of Americans taking a probiotic supplement increased four-fold to nearly 3 million adults and 294,000 children for different indications including UTI

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research